NFKB1 and metabolic dysfunction-associated steatohepatitis: LPS deteriorates NASH progression mainly by inducing the hepatic inflammatory response and fibrosis via LPS/TLR4 and NF-κB signaling pathways(Figure 1) in hepatocytes, hepatic stellate cells (HSCs) and Kupfer cells (54).